Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinoma
- PMID: 21328329
- PMCID: PMC3266661
- DOI: 10.1002/cncr.25973
Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinoma
Abstract
Background: Preoperative chemoradiation for rectal cancer can decrease the number of evaluable lymph nodes. Hence, the prognostic role of lymph node evaluation in patients with rectal cancer who receive preoperative chemoradiation is unclear. The authors of this report evaluated the prognostic impact of the number of lymph nodes examined in patients with rectal cancer who had negative lymph nodes based on the pathologic extent of disease (ypN0) after they received preoperative chemoradiation.
Methods: Between 1990 and 2004, 372 patients with nonmetastatic rectal adenocarcinoma received preoperative chemoradiation followed by mesorectal excision and had ypN0 disease. The median radiation dose was 45 gray, and 68% of patients received adjuvant chemotherapy.
Results: Patients had a median of 7 lymph nodes examined after preoperative chemoradiation. Compared with patients who had ≤7 lymph nodes examined, patients who had >7 lymph nodes had higher 5-year rates of freedom from relapse (86% vs 72%; log-rank P = .005) and cancer-specific survival (95% vs 86%; log-rank P = .0004), but no significant difference was observed in the overall survival rate (87% vs 81%; log-rank P = .07). Multivariate Cox proportional models demonstrated that patients who had >7 lymph nodes examined had a significantly lower risk of relapse (hazard ratio [HR], 0.39; P = .003) and death from rectal cancer (HR, 0.45; P = .04) but a similar risk of all-cause mortality (HR, 0.75; 95% CI, 0.46-1.20; P = .23) compared with patients who had ≤7 lymph nodes examined.
Conclusions: The number of lymph nodes examined was associated independently with disease relapse and cancer-specific survival in patients with rectal cancer who had ypN0 disease after receiving preoperative chemoradiation. Hence, the authors concluded that the number of negative lymph nodes examined may be a prognostic factor in patients with rectal cancer who receive preoperative chemoradiation.
Copyright © 2011 American Cancer Society.
Conflict of interest statement
CONFLICT OF INTEREST DISCLOSURES
The authors made no disclosures.
Figures



Similar articles
-
Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy.J Clin Oncol. 2008 May 1;26(13):2106-11. doi: 10.1200/JCO.2007.12.7704. Epub 2008 Mar 24. J Clin Oncol. 2008. PMID: 18362367
-
Lymph node yield in rectal cancer surgery: effect of preoperative chemoradiotherapy.Eur J Surg Oncol. 2010 Apr;36(4):345-9. doi: 10.1016/j.ejso.2009.12.006. Epub 2010 Jan 13. Eur J Surg Oncol. 2010. PMID: 20071133
-
The reliability of lymph-node staging in rectal cancer after preoperative chemoradiotherapy.Clin Oncol (R Coll Radiol). 2005 Sep;17(6):448-55. doi: 10.1016/j.clon.2005.05.007. Clin Oncol (R Coll Radiol). 2005. PMID: 16149289
-
Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision.Medicine (Baltimore). 2016 Mar;95(9):e2988. doi: 10.1097/MD.0000000000002988. Medicine (Baltimore). 2016. PMID: 26945418 Free PMC article.
-
The effects of preoperative chemoradiotherapy on lymph node sampling in rectal cancer.Dis Colon Rectum. 2012 Sep;55(9):1002-7. doi: 10.1097/DCR.0b013e3182536d70. Dis Colon Rectum. 2012. PMID: 22874609 Review.
Cited by
-
Increased lymph node yield indicates improved survival in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.Cancer Med. 2019 Aug;8(10):4615-4625. doi: 10.1002/cam4.2372. Epub 2019 Jun 28. Cancer Med. 2019. PMID: 31250569 Free PMC article.
-
Pathologic Complete Response Despite Nodal Yield Has Best Survival in Locally Advanced Rectal Cancer.J Surg Res. 2020 Jul;251:220-227. doi: 10.1016/j.jss.2020.01.019. Epub 2020 Mar 12. J Surg Res. 2020. PMID: 32172008 Free PMC article.
-
Laparoscopic versus open surgery following neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and meta-analysis.J Gastrointest Surg. 2014 Mar;18(3):617-26. doi: 10.1007/s11605-014-2452-1. Epub 2014 Jan 15. J Gastrointest Surg. 2014. PMID: 24424713
-
A lower cut-off for lymph node harvest predicts for poorer overall survival after rectal surgery post neoadjuvant chemoradiotherapy.World J Surg Oncol. 2020 Mar 20;18(1):58. doi: 10.1186/s12957-020-01833-8. World J Surg Oncol. 2020. PMID: 32197615 Free PMC article.
-
Prognostic impact of the number of lymph nodes examined in different stages of colorectal mucinous adenocarcinoma.Onco Targets Ther. 2018 Jun 25;11:3659-3670. doi: 10.2147/OTT.S163076. eCollection 2018. Onco Targets Ther. 2018. PMID: 29983574 Free PMC article.
References
-
- Caplin S, Cerottini JP, Bosman FT, Constanda MT, Givel JC. For patients with Dukes’ B (TNM stage II) colorectal carcinoma, examination of 6 or fewer lymph nodes is related to poor prognosis. Cancer. 1998;83:666–672. - PubMed
-
- Cianchi F, Palomba A, Boddi V, et al. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined. World J Surg. 2002;26:384–389. - PubMed
-
- Sarli L, Bader G, Iusco D, et al. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Eur J Cancer. 2005;41:272–279. - PubMed
-
- Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007;99:433–441. - PubMed
-
- Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of Intergroup Trial INT-0089. J Clin Oncol. 2003;21:2912–2919. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources